Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Leukemia

Free Subscription Articles published in Acta Haematol Retrieve available abstracts of 90 articles: HTML format

Single Articles

June 2021
1. CRISTIANO G, Nanni J, Sartor C, Parisi S, et al
   Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement.
   Acta Haematol. 2021 Jun 15:1-5. doi: 10.1159/000516003.
   PubMed     Abstract available
   
   
   
2. DANYLESKO I, Canaani J, Shimoni A, Fein J, et al
   Complete Remission with Incomplete Blood Count Recovery Is a Strong Predictor of Nonrelapse Mortality in Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.
   Acta Haematol. 2021 Jun 8:1-7. doi: 10.1159/000515902.
   PubMed     Abstract available
   
   
   April 2021
3. ZHANG X, Liu H, Zheng C, Tang B, et al
   Outcomes of Adolescents and Young Adults Compared with Children with Acute Leukemia after Single-Unit Unrelated Cord Blood Transplantation Using Myeloablative Conditioning without Antithymocyte Globulin.
   Acta Haematol. 2021 Apr 13:1-11. doi: 10.1159/000507973.
   PubMed     Abstract available
   
   
   March 2021
4. AITKEN MJL, Benton CB, Issa GC, Sasaki K, et al
   Two Cases of Possible Familial Chronic Myeloid Leukemia in a Family with Extensive History of Cancer.
   Acta Haematol. 2021 Mar 18:1-6. doi: 10.1159/000513925.
   PubMed     Abstract available
   
   
   February 2021
5. LANGERBEINS P, Eichhorst B
   Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic.
   Acta Haematol. 2021 Feb 25:1-11. doi: 10.1159/000514071.
   PubMed     Abstract available
   
   
   
6. WU B, Mao ZJ, Wang Z, Wu P, et al
   Deoxycytidine Kinase (DCK) Mutations in Human Acute Myeloid Leukemia Resistant to Cytarabine.
   Acta Haematol. 2021 Feb 24:1-8. doi: 10.1159/000513696.
   PubMed     Abstract available
   
   
   December 2020
7. HERBORG LL, Nederby L, Brondum RF, Hansen M, et al
   Antigen Expression Varies Significantly between Molecular Subgroups of Acute Myeloid Leukemia Patients: Clinical Applicability Is Hampered by Establishment of Relevant Cutoffs.
   Acta Haematol. 2020 Dec 3:1-10. doi: 10.1159/000510504.
   PubMed     Abstract available
   
   
   November 2020
8. SMOLEWSKI P, Robak T
   Current Treatment of Refractory/Relapsed Chronic Lymphocytic Leukemia: A Focus on Novel Drugs.
   Acta Haematol. 2020 Nov 25:1-15. doi: 10.1159/000510768.
   PubMed     Abstract available
   
   
   
9. SAMRA B, Kantarjian HM, Sasaki K, Alotaibi AS, et al
   Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of Transplant.
   Acta Haematol. 2020 Nov 25:1-8. doi: 10.1159/000510112.
   PubMed     Abstract available
   
   
   
10. TAKAHASHI S
    Current Understandings of Myeloid Differentiation Inducers in Leukemia Therapy.
    Acta Haematol. 2020 Nov 20:1-9. doi: 10.1159/000510980.
    PubMed     Abstract available
    
    
    August 2020
11. PATEL SA, Bledsoe JR, Gordon J, Cerny J, et al
    Extramedullary Acute Myeloid Leukemia of the Renal Pelvis: Insights into a Visceral Niche.
    Acta Haematol. 2020 Aug 19:1-5. doi: 10.1159/000508526.
    PubMed     Abstract available
    
    
    June 2020
12. OLSON AL, Saliba RM, Oran B, Chen J, et al
    Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
    Acta Haematol. 2020 Jun 30:1-8. doi: 10.1159/000507012.
    PubMed     Abstract available
    
    
    
13. ALHUMAID MS, Dasouki MJ, Ahmed SO, AbalKhail H, et al
    Comprehensive Genomic Analysis of Noonan Syndrome and Acute Myeloid Leukemia in Adults: A Review and Future Directions.
    Acta Haematol. 2020 Jun 15:1-11. doi: 10.1159/000505715.
    PubMed     Abstract available
    
    
    May 2020
14. ALANAZI W, Chen S, Lipton JH, Kim DD, et al
    Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome.
    Acta Haematol. 2020 May 19:1-8. doi: 10.1159/000507536.
    PubMed     Abstract available
    
    
    
15. SELLNER L
    T-Cell Prolymphocytic Leukemia: Long-Term Remissions Challenging!
    Acta Haematol. 2020 May 11:1-2. doi: 10.1159/000507469.
    PubMed    
    
    
    
16. PAUL S, Rausch CR, Jain N, Kadia T, et al
    Treating Leukemia in the Time of COVID-19.
    Acta Haematol. 2020 May 11:1-13. doi: 10.1159/000508199.
    PubMed     Abstract available
    
    
    
17. WAHNSCHAFFE L, Herling M
    What to Look Out for when Transplanting T-Cell Prolymphocytic Leukemia.
    Acta Haematol. 2020 May 5:1-3. doi: 10.1159/000507415.
    PubMed    
    
    
    April 2020
18. POH C, Arora M, Ghuman S, Tuscano J, et al
    Belinostat in Relapsed/Refractory T-Cell Large Granular Lymphocyte Leukemia.
    Acta Haematol. 2020 Apr 29:1-5. doi: 10.1159/000506918.
    PubMed     Abstract available
    
    
    
19. SHUMILOV E, Hasenkamp J, Szuszies CJ, Koch R, et al
    Patterns of Late Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with T-Cell Prolymphocytic Leukemia.
    Acta Haematol. 2020 Apr 7:1-6. doi: 10.1159/000506302.
    PubMed     Abstract available
    
    
    March 2020
20. TIMEUS F
    Noonan Syndrome and Acute Myeloid Leukemia in Adults: The Importance of a Correct Multidisciplinary Approach during Childhood.
    Acta Haematol. 2020 Mar 10:1-2. doi: 10.1159/000506388.
    PubMed    
    
    
    January 2020
21. BERNARDI S, Malagola M, Polverelli N, Russo D, et al
    Exosomes in Chronic Myeloid Leukemia: Are We Reading a New Reliable Message?
    Acta Haematol. 2020 Jan 9:1-2. doi: 10.1159/000505088.
    PubMed    
    
    
    
22. RAANANI P, Sharf G
    Interview with a Patients' Advocate.
    Acta Haematol. 2020;143:1-4.
    PubMed    
    
    
    
23. KUAN JW, Su AT, Leong CF, Osato M, et al
    Systematic Review of Normal Subjects Harbouring BCR-ABL1 Fusion Gene.
    Acta Haematol. 2020;143:96-111.
    PubMed     Abstract available
    
    
    
24. BANKAR A, Lipton JH
    Tyrosine Kinase Inhibitors in the Clinical Setting: A Conundrum of Choices.
    Acta Haematol. 2020;143:191-193.
    PubMed    
    
    
    
25. MAITI A, Franquiz MJ, Ravandi F, Cortes JE, et al
    Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias.
    Acta Haematol. 2020;143:567-573.
    PubMed     Abstract available
    
    
    December 2019
26. AMITAI I, Lipton JH
    Avoiding the Thorns of the Gifted Red Rose: Case Report of Late Diagnosis of Polycythemia Rubra Vera in a Sibling Bone Marrow Transplantation Donor for a Patient with Chronic Myeloid Leukemia.
    Acta Haematol. 2019 Dec 18:1-2. doi: 10.1159/000504740.
    PubMed    
    
    
    November 2019
27. PAPADANTONAKIS N
    FLAG and Etoposide as Salvage Treatment in Acute Myeloid Leukemia.
    Acta Haematol. 2019 Nov 21:1-2. doi: 10.1159/000504379.
    PubMed    
    
    
    October 2019
28. WESTHUS J, Noppeney R, Schmitz C, Flasshove M, et al
    Etoposide Combined with FLAG Salvage Therapy Is Effective in Multiple Relapsed/Refractory Acute Myeloid leukemia.
    Acta Haematol. 2019 Oct 25:1-8. doi: 10.1159/000503056.
    PubMed     Abstract available
    
    
    
29. PAROVICHNIKOVA E, Troitskaya V, Sokolov A, Gavrilina O, et al
    Can Less Intensive Chemotherapy and an Autotransplant Cure Adult T-Cell Acute Lymphoblastic Leukemia?
    Acta Haematol. 2019 Oct 9:1-9. doi: 10.1159/000502435.
    PubMed     Abstract available
    
    
    
30. SAUSSELE S, Haverkamp W, Lang F, Koschmieder S, et al
    Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management.
    Acta Haematol. 2019 Oct 7:1-15. doi: 10.1159/000501927.
    PubMed     Abstract available
    
    
    September 2019
31. PAN P, Wang L, Wang Y, Shen L, et al
    Systematic Review and Meta-Analysis of -New-Generation Tyrosine Kinase Inhibitors versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia.
    Acta Haematol. 2019 Sep 12:1-13. doi: 10.1159/000501537.
    PubMed     Abstract available
    
    
    August 2019
32. JIANG H, Li C, Liu Z
    Expression and Relationship of SAMHD1 with Other Apoptotic and Autophagic Genes in Acute Myeloid Leukemia Patients.
    Acta Haematol. 2019 Aug 21:1-9. doi: 10.1159/000500822.
    PubMed     Abstract available
    
    
    July 2019
33. KEMPIN S, Sun Z, Kay NE, Paietta EM, et al
    Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903).
    Acta Haematol. 2019 Jul 23:1-9. doi: 10.1159/000500164.
    PubMed     Abstract available
    
    
    
34. BRUNNER AM
    Acute Myeloid Leukemia: A New Era of Therapies, a New Wave of Toxicities?
    Acta Haematol. 2019 Jul 17:1-2. doi: 10.1159/000501330.
    PubMed    
    
    
    
35. SHIMONY S, Reiss Mintz H, Shvartser Beryozkin Y, Shoham A, et al
    Necrotizing Hemorrhagic Gastritis following Acute Myeloid Leukemia Induction with Midostaurin: An Unexpected Complication.
    Acta Haematol. 2019 Jul 10:1-4. doi: 10.1159/000500975.
    PubMed     Abstract available
    
    
    
36. LI Y, You MJ, Yang Y, Hu D, et al
    The Role of Tumor-Associated Macrophages in Leukemia.
    Acta Haematol. 2019 Jul 9:1-6. doi: 10.1159/000500315.
    PubMed     Abstract available
    
    
    
37. SCHALLER T, Herold N
    Evidence for SAMHD1 Tumor Suppressor Functions in Acute Myeloid Leukemia.
    Acta Haematol. 2019 Jul 8:1-2. doi: 10.1159/000501148.
    PubMed    
    
    
    June 2019
38. GUO Z, Chen Z, Xu Y, Zhang Y, et al
    The Association of Circulating T Follicular Helper Cells and Regulatory Cells with Acute Myeloid Leukemia Patients.
    Acta Haematol. 2019 Jun 18:1-7. doi: 10.1159/000500588.
    PubMed     Abstract available
    
    
    
39. ZHANG Y, Gu H, Chen Q, Zhang Y, et al
    Low Platelet Counts at Diagnosis Predict Better Survival for Patients with Intermediate-Risk Acute Myeloid Leukemia.
    Acta Haematol. 2019 Jun 5:1-10. doi: 10.1159/000500230.
    PubMed     Abstract available
    
    
    May 2019
40. SANTOPIETRO M, Miano M, Palumbo G, Zhang K, et al
    Atypical Chronic Myeloid Leukemia in a Patient with Aplastic Anemia.
    Acta Haematol. 2019 May 21:1-2. doi: 10.1159/000497137.
    PubMed    
    
    
    
41. BRECCIA M
    Can Chronic-Phase Chronic Myeloid Leukemia Patients Achieve Optimal and Durable Responses after Two Failed TKI Treatments? Real-World Evidence Data.
    Acta Haematol. 2019 May 21:1-3. doi: 10.1159/000496449.
    PubMed    
    
    
    
42. ZENG Z, Liu W, Benton CB, Konoplev S, et al
    Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell Transplantation.
    Acta Haematol. 2019 May 21:1-9. doi: 10.1159/000495456.
    PubMed     Abstract available
    
    
    April 2019
43. FELD J, Arnason J, O Apos Brien K, Nahas M, et al
    Hot and Cold: A Concurrent Warm and Cold Autoimmune Hemolytic Anemia in B-cell Prolymphocytic Leukemia.
    Acta Haematol. 2019;141:222-224.
    PubMed    
    
    
    February 2019
44. LI Z, Liu Y, Wang Q, Chen L, et al
    Autologous Stem Cell Transplantation Is a Viable Postremission Therapy for Intermediate-Risk Acute Myeloid Leukemia in First Complete Remission in the Absence of a Matched Identical Sibling: A Meta-Analysis.
    Acta Haematol. 2019;141:164-175.
    PubMed     Abstract available
    
    
    
45. TAHARA K, Koiso H, Osaki YH, Sekigami T, et al
    Malignancy-Associated Hypercalcemia Related with Receptor Activator of NF-kappaB Ligand (RANKL) Expression in T-Cell Acute Lymphoblastic Leukemia.
    Acta Haematol. 2019;141:135-137.
    PubMed    
    
    
    January 2019
46. BIELORAI B, Leitner M, Goldstein G, Mehrian-Shai R, et al
    Sustained Response to Imatinib in a Pediatric Patient with Concurrent Myeloproliferative Disease and Lymphoblastic Lymphoma Associated with a CCDC88C-PDGFRB Fusion Gene.
    Acta Haematol. 2019;141:119-127.
    PubMed     Abstract available
    
    
    
47. EL CHAER F, Holtzman NG, Sausville EA, Law JY, et al
    Relapsed Philadelphia Chromosome-Positive Pre-B-ALL after CD19-Directed CAR-T Cell Therapy Successfully Treated with Combination of Blinatumomab and Ponatinib.
    Acta Haematol. 2019;141:107-110.
    PubMed     Abstract available
    
    
    
48. SCHNEIDEWIND L, Neumann T, Zimmermann K, Weigel M, et al
    Is BK Virus-Associated Cystitis a Generalized Epithelial Disease?
    Acta Haematol. 2019;141:65-67.
    PubMed     Abstract available
    
    
    
49. RUIZ-ARGUELLES GJ
    Factors Involved in the Selection of Treatment in Patients with Hematological Malignancies.
    Acta Haematol. 2019;141:54.
    PubMed    
    
    
    
50. SHARGIAN-ALON L, Raanani P, Rozovski U, Siegal T, et al
    Immune Mediated Cerebellar Ataxia: An Unknown Manifestation of Graft-versus-Host Disease.
    Acta Haematol. 2019;141:19-22.
    PubMed     Abstract available
    
    
    
51. BAIN BJ, Bene MC
    Morphological and Immunophenotypic Clues to the WHO Categories of Acute Myeloid Leukaemia.
    Acta Haematol. 2019;141:232-244.
    PubMed     Abstract available
    
    
    
52. MULLER-THOMAS C, Tuchler H, Rudelius M, Schneider H, et al
    Serum Vitamin D Levels in Patients with Myelodysplastic Syndromes: A Retrospective Single-Center Analysis.
    Acta Haematol. 2019;141:225-231.
    PubMed     Abstract available
    
    
    
53. TIRRO E, Stella S, Massimino M, Zammit V, et al
    Colony-Forming Cell Assay Detecting the Co-Expression of JAK2V617F and BCR-ABL1 in the Same Clone: A Case Report.
    Acta Haematol. 2019;141:261-267.
    PubMed     Abstract available
    
    
    
54. MO HY, Kim MS, Chung NG, Yoo NJ, et al
    Promoter Mutation Analysis of LEPROTL1 Gene in Acute Leukemias and Solid Tumors.
    Acta Haematol. 2019;141:214-215.
    PubMed    
    
    
    
55. TAN J, Xue M, Pan J, Cen J, et al
    Responses to Dasatinib as a Second- and Third-Line Tyrosine Kinase Inhibitor in Chronic Phase Chronic Myeloid Leukaemia Patients.
    Acta Haematol. 2019;142:79-86.
    PubMed     Abstract available
    
    
    
56. SUCH E, Liquori A, Mora E, Marco-Ayala J, et al
    RNA Sequencing Analysis for the Identification of a PCM1/PDGFRB Fusion Gene Responsive to Imatinib.
    Acta Haematol. 2019;142:92-97.
    PubMed     Abstract available
    
    
    
57. CAO Y, Yao L, Liu Y, Gu Q, et al
    An Atypical PML-RARA Rearrangement Resulting from Submicroscopic Insertion of the RARA Gene at the PML Locus with Novel Breakpoints within PML Exon 7b and RARA Exon 3.
    Acta Haematol. 2019;142:98-104.
    PubMed     Abstract available
    
    
    
58. DEVOS T, Verhoef G, Steel E, Mazure D, et al
    Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium.
    Acta Haematol. 2019;142:197-207.
    PubMed     Abstract available
    
    
    December 2018
59. WANG L, Xu J, Tian X, Lv T, et al
    Analysis of Efficacy and Prognostic Factors of CLAG Treatment in Chinese Patients with Refractory or Relapsed Acute Myeloid Leukemia.
    Acta Haematol. 2018;141:43-53.
    PubMed     Abstract available
    
    
    November 2018
60. ABRUZZESE E, Trawinska MM, Neri B, Bondanini F, et al
    Successful Decitabine Treatment in Unfit, Elderly Patients with Acute Myeloid Leukemia following Chronic Myeloproliferative Neoplasm.
    Acta Haematol. 2018;140:231-233.
    PubMed    
    
    
    October 2018
61. CHOTSAMPANCHAROEN T, Sripornsawan P, Duangchu S, Wongchanchailert M, et al
    Survival Outcome of Alternative Medicine Treatment for Newly Diagnosed Acute Leukemia in Children.
    Acta Haematol. 2018;140:203-208.
    PubMed     Abstract available
    
    
    
62. NACHMIAS B, Shaulov A, Gatt ME, Shapira M, et al
    A Bortezomib-Based Protocol Induces a High Rate of Complete Remission with Minor Toxicity in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.
    Acta Haematol. 2018;140:209-214.
    PubMed     Abstract available
    
    
    
63. JIANG L, Deng T, Wang D, Xiao Y, et al
    Elevated Serum Exosomal miR-125b Level as a Potential Marker for Poor Prognosis in Intermediate-Risk Acute Myeloid Leukemia.
    Acta Haematol. 2018;140:183-192.
    PubMed     Abstract available
    
    
    September 2018
64. GIONA F, Santopietro M, Menna G, Putti MC, et al
    Real-Life Management of Children and Adolescents with Chronic Myeloid Leukemia: The Italian Experience.
    Acta Haematol. 2018;140:105-111.
    PubMed     Abstract available
    
    
    
65. NAESENS L, Devos H, Nollet F, Michaux L, et al
    Mediastinal Myeloid Sarcoma with TP53 Mutation Preceding Acute Myeloid Leukemia with a PICALM-MLLT10 Fusion Gene.
    Acta Haematol. 2018;140:97-104.
    PubMed     Abstract available
    
    
    
66. HA M, Kim JY, Han ME, Kim GH, et al
    TMEM18: A Novel Prognostic Marker in Acute Myeloid Leukemia.
    Acta Haematol. 2018;140:71-76.
    PubMed     Abstract available
    
    
    August 2018
67. ROZOVSKI U, Keating MJ, Estrov Z
    Why Is the Immunoglobulin Heavy Chain Gene Mutation Status a Prognostic Indicator in Chronic Lymphocytic Leukemia?
    Acta Haematol. 2018;140:51-54.
    PubMed     Abstract available
    
    
    
68. ABOU DALLE I, Cortes JE, Pinnamaneni P, Lamothe B, et al
    A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia.
    Acta Haematol. 2018;140:30-39.
    PubMed     Abstract available
    
    
    June 2018
69. PARK HS, Kim DY, Choi EJ, Lee JH, et al
    Blast Percentage of Bone Marrow Aspirate on Day 14 of Induction Chemotherapy Predicts Adult Acute Lymphoblastic Leukemia Treatment Outcomes.
    Acta Haematol. 2018;139:220-227.
    PubMed     Abstract available
    
    
    March 2018
70. SCHNEIDEWEND R, Hosking P, Brazauskas R, Peterson J, et al
    Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy.
    Acta Haematol. 2018;139:171-175.
    PubMed    
    
    
    February 2018
71. SONG X, Peng Y, Wang X, Chen Y, et al
    Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001-201
    Acta Haematol. 2018;139:115-127.
    PubMed     Abstract available
    
    
    
72. BRUNNER AM
    No Mutation Left Behind: The Impact of Reporting Recurrent Genetic Abnormalities on Outcomes of Patients with Acute Myeloid Leukemia.
    Acta Haematol. 2018;139:128-130.
    PubMed    
    
    
    
73. BARON BW, Thirman MJ, Giurcanu MC, Baron JM, et al
    Quercetin Therapy for Selected Patients with PIM1 Kinase-Positive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pilot Study.
    Acta Haematol. 2018;139:132-139.
    PubMed     Abstract available
    
    
    
74. TANG X, Zhou J, Zhang J, Zhou LY, et al
    Low Expression of FUS1 Is Negatively Correlated with miR-378 and May Predict Adverse Prognoses in Acute Myeloid Leukemia.
    Acta Haematol. 2018;139:89-95.
    PubMed     Abstract available
    
    
    January 2018
75. NISCOLA P, Neri B, Morino L, de Fabritiis P, et al
    Monoclonal Gammopathy Responsive to Decitabine Given for Acute Myeloid Leukemia in a Frail Patient.
    Acta Haematol. 2018;139:58-59.
    PubMed    
    
    
    
76. LV H, Hu S, Lu J, Zhai Q, et al
    Precursor T-Lymphoblastic Lymphoma Associated with t(8;9)(p11.2;q33): A Case Report and Review of the Literature.
    Acta Haematol. 2018;139:176-182.
    PubMed     Abstract available
    
    
    September 2017
77. LEADER A, Raanani P
    Switching-On Adherence in Chronic Myeloid Leukemia.
    Acta Haematol. 2017;138:138-139.
    PubMed    
    
    
    
78. MAEDA Y, Okamoto A, Kawaguchi SI, Konishi A, et al
    Improved Drug Adherence in Patients with Chronic Myeloid Leukemia in the Chronic Phase by Switching to Second-Generation Tyrosine Kinase Inhibitors.
    Acta Haematol. 2017;138:140-142.
    PubMed    
    
    
    
79. LIEBERMAN F, Villgran V, Normolle D, Boyiadzis M, et al
    Intracranial Hemorrhage in Patients Newly Diagnosed with Acute Myeloid Leukemia and Hyperleukocytosis.
    Acta Haematol. 2017;138:116-118.
    PubMed    
    
    
    July 2017
80. TIMMERMANS K, Leijte GP, Kox M, Scheffer GJ, et al
    Release of Danger-Associated Molecular Patterns following Chemotherapy Does Not Induce Immunoparalysis in Leukemia Patients.
    Acta Haematol. 2017;138:39-43.
    PubMed     Abstract available
    
    
    
81. ANAGNOSTOPOULOU E, Papanastasopoulou C, Papastamataki M, Kotsiou A, et al
    Serum Hyaluronic Acid Levels Are Altered in Acute Leukemia Patients: Potential Prognostic Implications.
    Acta Haematol. 2017;138:44-51.
    PubMed     Abstract available
    
    
    
82. HERNANDEZ-RIVAS JA, Gonzalez-Gascon Y Marin I
    Genetic Heterogeneity in Chronic Lymphocytic Leukemia: What Can Conventional Cytogenetics Add?
    Acta Haematol. 2017;138:31-32.
    PubMed    
    
    
    June 2017
83. CHANG H, Kuo MC, Tang TC, Lin TL, et al
    Clinical Features and Recurrence Pattern of Perianal Abscess in Patients with Acute Myeloid Leukemia.
    Acta Haematol. 2017;138:10-13.
    PubMed     Abstract available
    
    
    May 2017
84. PETERSON JF, Shah R, Kobrinski D
    Two Distinct BCL2 Rearrangements, Each Observed in 2 Independent Subclones, Evolving from a Founder Clone with Trisomy 12 in a Unique Case of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Acta Haematol. 2017;137:237-239.
    PubMed    
    
    
    April 2017
85. ZHAO H, Xu L, Yang Y, Shao J, et al
    Successful Management of Decitabine prior to Full-Dose Idarubicin and Cytarabine in the Treatment of Refractory/Recurrent Acute Myeloid Leukemia.
    Acta Haematol. 2017;137:195-200.
    PubMed     Abstract available
    
    
    
86. LI Y, Wang CL, Din B, Yu L, et al
    Continuing Imatinib Treatment for Chronic Myeloid Leukemia Patients Who Had Serious Adverse Events at the Onset of Therapy.
    Acta Haematol. 2017;137:158-162.
    PubMed    
    
    
    
87. PTACKOVA P, Petrackova M, Hindos M, Duskova M, et al
    Intracellular Cytokines Produced by Stimulated CD3+ Cells from Chronic Myeloid Leukemia Patients.
    Acta Haematol. 2017;137:148-157.
    PubMed     Abstract available
    
    
    January 2017
88. GUREVICH-SHAPIRO A, Tzadok S, Rosenberg A, Inbal A, et al
    Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience.
    Acta Haematol. 2017;137:183-190.
    PubMed     Abstract available
    
    
    
89. LIANG Y, Gao J, Wu D, Li S, et al
    Long-Term Remission following Autologous Hematopoietic Cell Transplantation in a Patient with Multiple Nonleukemic Myeloid Sarcoma and a Review of the Literature.
    Acta Haematol. 2017;137:117-122.
    PubMed     Abstract available
    
    
    
90. SCHNEIDEWIND L, Neumann T, Knoll F, Zimmermann K, et al
    Are the Polyomaviruses BK and JC Associated with Opportunistic Infections, Graft-versus-Host Disease, or Worse Outcomes in Adult Patients Receiving Their First Allogeneic Stem Cell Transplantation with Low-Dose Alemtuzumab?
    Acta Haematol. 2017;138:3-9.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: